Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEBoard MeetingResults4 Nov 2026

Computer Point Ltd

Computer Point Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve Board Meeting is Scheduled to be held on 11th November,2026 at to consider and Adopt the Unaudited Financial Results for the Quarter and Half Year Ended 30.09.2026

Computer Point Ltd has scheduled a Board Meeting on 11th November, 2026 to consider and approve the Unaudited Financial Results for the Quarter and Half Year Ended 30.09.2026.

Read more →📎 1 attachment
BSEResultResults4 Nov 2026

Redington Ltd

Financial Results - Q2 & H1 FY 2026-27

Redington Ltd has announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, with revenue from operations at ₹25,224.83 crore and ₹42,946.91 crore respectively.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults4 Nov 2026

Marksans Pharma Limited

Investor Presentation

Marksans Pharma Limited has informed the Exchange about Investor Presentation for Q2FY27, with revenue reaching ₹940 crore, up 30.5% YoY, and EBITDA growing 48.3% to a record ₹214 crore.

Read more →📎 1 attachment
BSEBoard MeetingResults4 Nov 2026

Lasa Supergenerics Ltd

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, November 14, 2026 inter alia; 1. ....

Lasa Supergenerics Ltd has scheduled a Board Meeting on November 14, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026.

Read more →📎 1 attachment
BSECorp. ActionResults4 Nov 2026

Dr. Lal PathLabs Ltd

Attached

Dr. Lal PathLabs Ltd announced its un-audited financial results for the quarter and half year ended September 30, 2026, declaring a 2nd interim dividend of INR 5 per equity share. The company also appointed Ms. Vasuta Agarwal as an Additional Director and approved further investment of up to INR 49.5 Crores in its subsidiary Dr. Lal PathLabs FZCO.

Read more →📎 1 attachment
BSEResultResults4 Nov 2026

Technopack Polymers Ltd

Unaudited Financial Results alongwith Limited Review Report of the Company for the half year ended on September 30, 2026

Technopack Polymers Ltd has announced unaudited financial results for the half year ended September 30, 2026, with the company's Board of Directors approving the results in a meeting held on November 4, 2026. The results show a total equity and liabilities of Rs. 2491.12 crores as of September 30, 2026, with a share capital of Rs. 1080 crores and reserves and surplus of Rs. 1091.37 crores.

Read more →📎 1 attachment
BSECompany UpdateResults4 Nov 2026

Jtekt India Ltd

Announcemnet under Regulation 30

Jtekt India Ltd has announced unaudited financial results for the second quarter ended 30th September, 2026, and approved a proposal to invest up to Rs. 2,40,00,000 in a Special Purpose Vehicle for a Group Captive Solar Power Project.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationResults4 Nov 2026

Goyal Aluminiums Limited

Copy of Newspaper Publication

Goyal Aluminiums Limited has informed the Exchange about the submission of newspaper advertisement pertaining to Un-Audited Financial Results for the quarter and half year ended 30th September, 2026.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults4 Nov 2026

Rolex Rings Limited

Outcome of Board Meeting

Rolex Rings Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors and reviewed by the Audit Committee.

Read more →📎 1 attachment
BSECorp ActionResults4 Nov 2026

Dr. Lal PathLabs Ltd

Attached

Dr. Lal PathLabs Ltd has announced its un-audited financial results for the quarter and half year ended September 30, 2026, along with the declaration of a 2nd interim dividend of INR 5 per equity share. The company has also appointed Ms. Vasuta Agarwal as an Additional Director and made further investments in its subsidiary company.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults4 Nov 2026

Dr. Lal Path Labs Ltd.

Outcome of Board Meeting

Dr. Lal Path Labs Ltd. has informed the Exchange regarding Outcome of Board Meeting held on November 04, 2026, where the Board of Directors considered, noted and approved the un-audited financial results for the quarter and half year ended September 30, 2026, declared 2nd interim dividend of INR 5/- per equity share, appointed Ms. Vasuta Agarwal as an Additional Director, and approved further investment in Dr. Lal PathLabs FZCO, a Wholly Owned Subsidiary of the Company.

Read more →📎 1 attachment
← PreviousPage 774 of 4427Next →